PharmaTher Archives

Psychedelics News

PharmaTher

Finance

29 Sep 2022

PharmaTher Provides Year-End Highlights and Financials

PharmaTher Provides Business Highlights and Releases Audited Annual Financials for Fiscal Year Ended May 31, 2022...

By Microdose NewsDesk

Don’t Miss

18 Jul 2022

News You Might Have Missed: July 18th, 2022

Welcome to the News You Might Have Missed, a weekly roundup of psychedelic medicine headlines to help you catch up and stay informed....

By Microdose NewsDesk

Industry

13 Jul 2022

PharmaTher Granted Patent For Ketamine and Parkinson’s

Today we received another addition to PharmaTher's IP stockpile with a new patent for ketamine and the treatment of Parkinson’s and other motor disorders....

By Jason Najum

Don’t Miss

13 Jun 2022

News You Might Have Missed: June 13th, 2022

Welcome to the News You Might Have Missed, a weekly roundup of psychedelic medicine headlines to help you catch up and stay informed....

By Microdose NewsDesk

Join Our Newsletter for Exclusive Updates, Stories, and More

Don’t Miss

19 Apr 2022

News You Might Have Missed: April 19th, 2022

Welcome to the News You Might Have Missed, a weekly roundup of psychedelic medicine news items to help you catch up and stay informed....

By Jason Najum

Industry

23 Mar 2022

Heading to Phase 3? PharmaTher Announces Positive Results for Ketamine Trial

If a Phase 3 study is actually in their near future, then PharmaTher would further solidify itself as a serious top tier firm and official king of Ketamine....

By Jason Najum

Industry

16 Feb 2022

PharmaTher Receives U.S. Patent For Ketamine

Today the company announced that it’s been granted a new patent for the combination of FDA-approved ketamine and PharmaTher’s proprietary betaine anhydrous (“KETABET™”)....

By Jason Najum

Finance

14 Jan 2022

Psychedelic Stocks to Watch in 2022

While 2022 hasn’t yet given us the market turnaround we had hoped for, the forthcoming 12 months will filled with clinical trial news and significant milestones....

By Jason Najum

Industry

13 Jan 2022

PharmaTher Receives FDA Approval for Ketamine Phase 2 Trial

PharmaTher has taken another important step in its clinical trial process....

By Microdose

Follow us on social

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result